Insider · CIK 0001658918
Christopher A. Kroeger
Files at MPLT (MapLight Therapeutics, Inc.). First filing Apr 17, 2026, latest Jul 17, 2026.
In brief
Christopher A. Kroeger files SEC Form 4 as CEO and director at MPLT (MapLight Therapeutics, Inc.). Since Apr 17, 2026, Christopher A. Kroeger has reported 0 open-market buys worth $0 and 5 open-market sells worth $13M, the latest filed on Jul 17, 2026.
A track record needs three past buys with six months of prices behind them; Christopher A. Kroeger has 0, so none is measured yet.
The newest scored trade: sold $5.4M of MPLT on Jul 15, 2026, filed Jul 17, 2026, scored 70 (notable). In the last 12 months: 0 buys worth $0 and 5 sells worth $13M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MPLT: MapLight Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 70Notable | MapLight Therapeutics, Inc. | $5.4M 147,639 shares | -11% | +191% from low-6% from high | |
| 45Moderate | MapLight Therapeutics, Inc. | $3.2M 118,235 shares | -8% | +107% from low-18% from high | |
| 45Moderate | MapLight Therapeutics, Inc. | $1.9M 68,491 shares | -4% | +128% from low-9% from high | |
| 45Moderate | MapLight Therapeutics, Inc. | $1.4M 49,744 shares | -3% | +123% from low-11% from high | |
| 58Moderate | MapLight Therapeutics, Inc. | $521k 19,187 shares | -1% | +110% from low-9% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | 152,230 0.36% of outstanding | $5.8M | Jul 15, 2026 | $7.4M |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | 236,470 0.56% of outstanding | $7.3M | May 4, 2026 | $521k |
| Apr 15, 2026 | MPLT MapLight Therapeutics, Inc. | 20,822 0.05% of outstanding | $563k | Apr 15, 2026 | none |
Transactions
Every row this insider has filed, 38 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +23,145 | $0.00 | $0 | 1,269,600 | Aug 19, 2026 |
| Aug 17, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +93,955 | $0.00 | $0 | 93,955 | Aug 19, 2026 |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -18,950 | $36.00 | $682k | 1,375,144 | Jul 17, 2026 |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -42,738 | $36.99 | $1.6M | 1,332,406 | Jul 17, 2026 |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -90 | $37.54 | $3,379 | 1,332,316 | Jul 17, 2026 |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -40,899 | $36.46 | $1.5M | 1,291,417 | Jul 17, 2026 |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -28,091 | $37.26 | $1.0M | 1,263,326 | Jul 17, 2026 |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -92 | $37.96 | $3,492 | 1,263,234 | Jul 17, 2026 |
| Jul 17, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -16,779 | $37.90 | $636k | 1,246,455 | Jul 17, 2026 |
| May 18, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -118,037 | $27.19 | $3.2M | 1,394,292 | May 18, 2026 |
| May 18, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -198 | $28.15 | $5,574 | 1,394,094 | May 18, 2026 |
| May 7, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -14,880 | $28.47 | $424k | 1,565,940 | May 11, 2026 |
| May 7, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -5,220 | $29.15 | $152k | 1,560,720 | May 11, 2026 |
| May 8, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -29,624 | $27.48 | $814k | 1,531,096 | May 11, 2026 |
| May 8, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -1,582 | $28.56 | $45k | 1,529,514 | May 11, 2026 |
| May 8, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -3,205 | $29.20 | $94k | 1,526,309 | May 11, 2026 |
| May 11, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -342 | $27.57 | $9,429 | 1,525,967 | May 11, 2026 |
| May 11, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -877 | $28.70 | $25k | 1,525,090 | May 11, 2026 |
| May 11, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -6,871 | $30.04 | $206k | 1,518,219 | May 11, 2026 |
| May 11, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -5,890 | $30.56 | $180k | 1,512,329 | May 11, 2026 |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -9,136 | $27.50 | $251k | 1,621,428 | May 6, 2026 |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -5,427 | $28.37 | $154k | 1,616,001 | May 6, 2026 |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -311 | $29.56 | $9,193 | 1,615,690 | May 6, 2026 |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -697 | $30.08 | $21k | 1,614,993 | May 6, 2026 |
| May 5, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -9,544 | $28.12 | $268k | 1,605,449 | May 6, 2026 |
| May 5, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -928 | $29.00 | $27k | 1,604,521 | May 6, 2026 |
| May 6, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -8,098 | $28.04 | $227k | 1,596,423 | May 6, 2026 |
| May 6, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -15,603 | $29.13 | $455k | 1,580,820 | May 6, 2026 |
| Apr 15, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -9,135 | $26.93 | $246k | 1,640,616 | Apr 17, 2026 |
| Apr 16, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -2,477 | $27.01 | $67k | 1,638,139 | Apr 17, 2026 |
| Apr 16, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -7,575 | $27.49 | $208k | 1,630,564 | Apr 17, 2026 |
| Feb 5, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +23,145 | $0.00 | $0 | 1,649,751 | Feb 9, 2026 |
| Feb 5, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +93,955 | $0.00 | $0 | 93,955 | Feb 9, 2026 |
| Jan 27, 2026 | MPLT MapLight Therapeutics, Inc. | FTax withholding Voting Common Stock | -204,146 | $17.98 | $3.7M | 1,626,606 | Jan 29, 2026 |
| Oct 27, 2025 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +225,693 | $0.00 | $0 | 225,693 | Oct 28, 2025 |
| Oct 28, 2025 | MPLT MapLight Therapeutics, Inc. | CConversion Voting Common Stock | +3,895 | - | - | 229,588 | Oct 28, 2025 |
| Oct 27, 2025 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +916,164 | $0.00 | $0 | 916,164 | Oct 28, 2025 |
| Oct 28, 2025 | MPLT MapLight Therapeutics, Inc. | CConversion Series C Preferred Stockderivative | -65,477 | $0.00 | $0 | 0 | Oct 28, 2025 |
Questions about Christopher A. Kroeger
Answered from the filings on this page, as of the latest one.
Is Christopher A. Kroeger buying or selling?
In the last 12 months Christopher A. Kroeger reported 0 open-market buys worth $0 and 5 open-market sells worth $13M on SEC Form 4; the latest was sold $5.4M of MPLT on Jul 15, 2026. Grants, option exercises and tax withholding are not counted.
How did Christopher A. Kroeger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher A. Kroeger has 0.
Where does Christopher A. Kroeger file Form 4?
Christopher A. Kroeger has filed Form 4 at MPLT (MapLight Therapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.